Contrasting STRATA Skin Sciences (NASDAQ:SSKN) and Neovasc (NASDAQ:NVCN)
STRATA Skin Sciences (NASDAQ:SSKN) and Neovasc (NASDAQ:NVCN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.
Institutional and Insider Ownership
32.1% of STRATA Skin Sciences shares are held by institutional investors. 45.6% of STRATA Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This is a breakdown of recent ratings and recommmendations for STRATA Skin Sciences and Neovasc, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|STRATA Skin Sciences||0||0||2||0||3.00|
STRATA Skin Sciences presently has a consensus price target of $6.00, suggesting a potential upside of 119.78%. Neovasc has a consensus price target of $9.00, suggesting a potential upside of 172.73%. Given Neovasc’s higher possible upside, analysts clearly believe Neovasc is more favorable than STRATA Skin Sciences.
Volatility & Risk
STRATA Skin Sciences has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500. Comparatively, Neovasc has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.
Earnings & Valuation
This table compares STRATA Skin Sciences and Neovasc’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|STRATA Skin Sciences||$29.85 million||2.74||-$4.03 million||N/A||N/A|
|Neovasc||$1.75 million||14.11||-$108.04 million||($27.30)||-0.12|
STRATA Skin Sciences has higher revenue and earnings than Neovasc.
This table compares STRATA Skin Sciences and Neovasc’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|STRATA Skin Sciences||N/A||N/A||N/A|
STRATA Skin Sciences beats Neovasc on 7 of the 9 factors compared between the two stocks.
About STRATA Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.